Cramer Rosenthal Mcglynn LLC Has $12.87 Million Stock Position in AMETEK, Inc. (NYSE:AME)

Cramer Rosenthal Mcglynn LLC lessened its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 71,404 shares of the technology company's stock after selling 2,957 shares during the quarter. Cramer Rosenthal Mcglynn LLC's holdings in AMETEK were worth $12,871,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Versant Capital Management Inc increased its stake in shares of AMETEK by 3,116.7% during the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock worth $35,000 after purchasing an additional 187 shares during the last quarter. AdvisorNet Financial Inc grew its holdings in AMETEK by 1,176.5% during the fourth quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock worth $39,000 after purchasing an additional 200 shares during the period. Geneos Wealth Management Inc. increased its position in AMETEK by 42.9% during the fourth quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company's stock worth $42,000 after buying an additional 70 shares during the last quarter. OFI Invest Asset Management acquired a new stake in shares of AMETEK in the fourth quarter valued at approximately $43,000. Finally, Anchor Investment Management LLC boosted its stake in shares of AMETEK by 366.1% during the 3rd quarter. Anchor Investment Management LLC now owns 261 shares of the technology company's stock worth $45,000 after acquiring an additional 205 shares during the period. 87.43% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on AME shares. StockNews.com cut AMETEK from a "buy" rating to a "hold" rating in a research note on Friday, April 11th. Robert W. Baird dropped their price objective on shares of AMETEK from $200.00 to $197.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Truist Financial reduced their target price on shares of AMETEK from $216.00 to $196.00 and set a "buy" rating for the company in a report on Tuesday, April 8th. Morgan Stanley started coverage on shares of AMETEK in a research report on Monday, April 14th. They set an "equal weight" rating and a $170.00 price objective for the company. Finally, BNP Paribas raised AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 target price on the stock in a research report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $198.60.

Insider Buying and Selling at AMETEK

In other AMETEK news, Director Steven W. Kohlhagen sold 1,320 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $189.41, for a total transaction of $250,021.20. Following the sale, the director now owns 22,029 shares of the company's stock, valued at approximately $4,172,512.89. The trade was a 5.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas A. Amato sold 710 shares of the stock in a transaction on Thursday, March 27th. The shares were sold at an average price of $176.64, for a total value of $125,414.40. Following the completion of the transaction, the director now owns 10,560 shares of the company's stock, valued at $1,865,318.40. The trade was a 6.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.57% of the company's stock.

AMETEK Price Performance

Shares of AME traded up $3.16 during trading hours on Wednesday, hitting $162.81. 581,595 shares of the company were exchanged, compared to its average volume of 1,286,723. The company has a market cap of $37.57 billion, a price-to-earnings ratio of 27.46, a P/E/G ratio of 2.73 and a beta of 1.14. The firm's fifty day moving average is $173.17 and its 200 day moving average is $179.53. AMETEK, Inc. has a fifty-two week low of $145.02 and a fifty-two week high of $198.33. The company has a quick ratio of 0.75, a current ratio of 1.24 and a debt-to-equity ratio of 0.15.

AMETEK (NYSE:AME - Get Free Report) last released its earnings results on Tuesday, February 4th. The technology company reported $1.87 EPS for the quarter, beating the consensus estimate of $1.85 by $0.02. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. The business's quarterly revenue was up 1.8% compared to the same quarter last year. During the same period last year, the firm earned $1.68 EPS. On average, equities analysts anticipate that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.

AMETEK Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, March 14th were issued a dividend of $0.31 per share. The ex-dividend date was Friday, March 14th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.76%. This is a boost from AMETEK's previous quarterly dividend of $0.28. AMETEK's payout ratio is 20.91%.

AMETEK announced that its board has approved a stock repurchase program on Friday, February 7th that allows the company to buyback $1.25 billion in outstanding shares. This buyback authorization allows the technology company to purchase up to 2.9% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.